Strategically Positioning Mayo Clinic to Address the Fragile Global Pharmaceutical Supply Chain
Jordan F. Down, PharmD, MS, FACHE and Eric M. Tichy, PharmD, MBA

LEARNING OBJECTIVES
Upon conclusion of this program, participants should be able to:

• Describe the current state of the global pharmaceutical supply chain structure
• Discuss the root cause of drug shortages and the impact on clinical practice within the Mayo Clinic Enterprise
• Explain Mayo Clinic strategic initiatives to promote responsible supply chain management and improve security of pharmaceutical supply
• Describe the performance of Mayo Clinic's pharmaceutical supply chain during the COVID-19 pandemic

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.